Aquino Maria Cecilia

Chan Kai En, Chan Nicole Shu-Wen, Liu Minxin, Aquino Maria Cecilia, Koh Victor Teck Chang, Lun Katherine Wanxian et al.

This meta-analysis found the PAUL glaucoma implant effectively lowered IOP and medication use in refractory glaucoma patients, with good safety and low complication rates, supporting its clinical utility.

Chan Nicole Shu-Wen, Hing Seah Wei, Okada Naoki, Hengtong Li, Aquino Maria Cecilia, Koh Teck Chang Victor et al.

Stent removal from Paul Glaucoma Implants was needed in under half of patients. It safely lowered IOP, with reduction correlating to pre-removal IOP, offering a controlled pressure drop.

Tan Marcus Chun Jin, Ong Chee Wui, Aquino Maria Cecilia, Lun Katherine Wanxian, Sng Chelvin Cheryl Agnes, Lim Dawn Ka Ann et al.

This study found the Paul Glaucoma Implant effectively lowered eye pressure and medication use for three years, with a 14.6% failure rate. This suggests it's a viable long-term glaucoma treatment.

Tan Marcus Chun Jin, Choy Heng Yoong Chloe, Koh Teck Chang Victor, Aquino Maria Cecilia, Sng Chelvin Cheryl Agnes, Lim Dawn Ka Ann et al.

The Paul Glaucoma Implant effectively lowered eye pressure and medication use for two years in advanced glaucoma patients, demonstrating a promising new treatment option.

Tong Weihan, Shen Tina Yu Ting, Wong Hung Chew, Aquino Maria Cecilia, Chew Paul, Lim Dawn

Micropulse cyclophototherapy for POAG offered modest, transient IOP lowering, with many patients still requiring subsequent surgery. It serves as a temporizing measure, not a definitive solution.

Asano Shotaro, Koh Teck Chang Victor, Aquino Maria Cecilia, Lim Ka-Ann Dawn, Sng Chelvin Cheryl Anges, Loon Seng Chee et al.

Combined cataract/GDD surgery had good refractive outcomes, similar to cataract surgery alone, except for short eyes. Trabeculectomy caused myopic error. This guides surgical planning for glaucoma patients.

Ng Jamie Y, Sng Chelvin C A, Liao Jiemin, Aquino Maria Cecilia, Chew Paul